Legal Subjectivity:
The country does not allow stem cells to be used. Now the country only allows stem cells to be used in clinical trials. The production output of conventional MSC preparation is limited, and only some institutions, such as research institutes, can provide qualified stem cells. Therefore, injecting stem cells can only be used clinically. Legal objectivity:
Article 1 of the "Technical Management Standards for the Collection of Non-Blood Hematopoietic Stem Cells" Medical institutions that collect hematopoietic stem cells should ensure that the source of hematopoietic stem cells is legal. (1) Professional diagnosis and treatment subjects of hematology and internal medicine approved and registered by the health administrative department. (2) Tertiary A hospitals or hematology hospitals. (3) Collection conditions 1. Collection room: There is a hematopoietic stem cell collection work area of ??more than 20m2; there are corresponding hematopoietic stem cell collection equipment, collection beds/chairs, etc. 2. There is a mobilizing agent injection room. 3. Can provide routine physical examination services to donors. 4. Emergency treatment area: It has corresponding rescue equipment and can carry out emergency treatment. 5. Have data storage and transmission equipment.